Skip to content
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact

Transgenic Platforms
for Antibody Generation

  • Antibody Generation
  • Antigen Design
  • OmniRat
  • OmniMouse
  • OmniChicken
  • OmnidAb
  • OmniTaur
  • Bispecific Platforms

World-class transgenic animals for unparalleled discovery of naturally optimized human antibodies®

Our proprietary transgenic animals, including OmniRat®, OmniChicken® and OmniMouse® have been genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic® and OmniClic® are fixed or common light-chain rats and chickens, respectively, designed to facilitate the discovery of bispecific antibodies. OmniTaur™ provides cow-inspired antibodies with unique structural characteristics for challenging targets.  OmnidAb®, is an in vivo platform for the discovery of single domain antibodies based upon a human VH scaffold that affinity matures in a chicken host environment to provide a functionally diverse immune repertoire unavailable from mammalian systems.  Our expertise in developing transgenic animal platforms ensures that they have the most flexible options for discovering high-quality antibody leads. We work closely with our partners’ teams to create effective transgenic animal models for human diseases to customize and optimize the process for every campaign. Get in touch with us today to learn more about our full capabilities. 
Learn more about the benefits of choosing OmniAb

Discover OmniAb’s suite of transgenic animals

The world’s only human lg-transgenic rats

OmniRat and OmniFlic are the only transgenic rats that generate human antibodies for the development of therapeutic monospecific and bispecific antibodies.

Human lg-transgenic mice for maximal flexibility in your discovery processes

OmniMouse delivers fully human antibodies using standard mouse-based protocols.

The world’s only human lg-transgenic chicken for antibody discovery

OmniChicken is optimized for human antibody research.

Heavy Chain-Only Transgenic Chickens

A human VH domain benefiting from being generated in a chicken host. Discover OmnidAb.

OmniTaur™ provides an ultra-long CDR-H3 platform

Discover OmniTaur.

Common light chain platforms for simplified bispecific antibody generation

OmniFlic rats and OmniClic chickens have been designed to overcome the light chain pairing challenge for the development of bispecific antibodies by expressing a single common kappa light chain.

About

  • Team
  • Board of Directors
  • Careers

Partnerships

  • Overview
  • Why Partner with OmniAb?
  • Partner Pipeline
  • Contact Business Development

Technology

  • Overview
  • Antigen Design
  • Antibody Generation
  • Antibody Optimization
  • Ion Channel and Transporter Technology
  • Scientific Publications

OmniAb, Inc.
5980 Horton Street
Suite 600
Emeryville, CA 94608

Contact | Privacy Policy | Disclaimer

© 2025 OmniAb, Inc. All rights reserved.